Literature DB >> 21580140

3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine.

Hakan Arslan, Semra Utku, Kenneth I Hardcastle, Mehtap Gökçe, Sheri Lense.   

Abstract

In the title compound, C(13)H(14)ClN(5), the piperazine ring adopts a chair conformation and the dihedral angle between the aromatic rings is 13.91 (7)°. The crystal structure is stabilized by weak inter-molecular C-H⋯N hydrogen-bond inter-actions.

Entities:  

Year:  2009        PMID: 21580140      PMCID: PMC2980189          DOI: 10.1107/S1600536809050727

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis, structures and analgesic and anti-inflammatory activity of substituted pyridazine derivatives, see: Boissier et al. (1963 ▶); Gokce et al. (2001 ▶, 2004 ▶, 2005 ▶, 2009 ▶); Sahin et al. (2004 ▶); Dundar et al. (2007 ▶). For general background to non-opioid analgesic derivatives, see: Sato et al. (1981 ▶); Banoglu et al. (2004 ▶); Giovannoni et al. (2003 ▶)·For puckering parameters, see: Cremer & Pople (1975 ▶).

Experimental

Crystal data

C13H14ClN5 M = 275.74 Triclinic, a = 5.912 (3) Å b = 8.088 (5) Å c = 13.689 (8) Å α = 83.359 (9)° β = 83.019 (9)° γ = 75.168 (9)° V = 625.5 (6) Å3 Z = 2 Mo Kα radiation μ = 0.30 mm−1 T = 296 K 0.16 × 0.15 × 0.14 mm

Data collection

Bruker APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2008 ▶) T min = 0.954, T max = 0.959 11395 measured reflections 3275 independent reflections 2264 reflections with I > 2σ(I) R int = 0.049

Refinement

R[F 2 > 2σ(F 2)] = 0.039 wR(F 2) = 0.095 S = 0.95 3275 reflections 172 parameters H-atom parameters constrained Δρmax = 0.27 e Å−3 Δρmin = −0.23 e Å−3 Data collection: APEX2 (Bruker (2008 ▶); cell refinement: SAINT (Bruker, 2008 ▶); data reduction: SAIn class="Chemical">NT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536809050727/hg2610sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809050727/hg2610Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C13H14ClN5Z = 2
Mr = 275.74F(000) = 288
Triclinic, P1Dx = 1.464 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 5.912 (3) ÅCell parameters from 2718 reflections
b = 8.088 (5) Åθ = 2.6–28.2°
c = 13.689 (8) ŵ = 0.30 mm1
α = 83.359 (9)°T = 296 K
β = 83.019 (9)°Block, colourless
γ = 75.168 (9)°0.16 × 0.15 × 0.14 mm
V = 625.5 (6) Å3
Bruker APEXII CCD diffractometer3275 independent reflections
Radiation source: fine-focus sealed tube2264 reflections with I > 2σ(I)
graphiteRint = 0.049
φ and ω scansθmax = 29.0°, θmin = 1.5°
Absorption correction: multi-scan (SADABS; Bruker, 2008)h = −8→7
Tmin = 0.954, Tmax = 0.959k = −10→11
11395 measured reflectionsl = −18→18
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.039Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.095H-atom parameters constrained
S = 0.95w = 1/[σ2(Fo2) + (0.0433P)2] where P = (Fo2 + 2Fc2)/3
3275 reflections(Δ/σ)max = 0.001
172 parametersΔρmax = 0.27 e Å3
0 restraintsΔρmin = −0.23 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.2600 (3)1.08679 (18)0.14549 (10)0.0258 (3)
C20.4977 (3)1.05027 (18)0.15814 (10)0.0262 (3)
H20.60451.08560.10980.031*
C30.5676 (2)0.96086 (18)0.24396 (10)0.0233 (3)
H30.72480.93140.25630.028*
C40.3929 (2)0.91394 (16)0.31412 (10)0.0183 (3)
C50.2554 (2)0.78257 (18)0.47211 (9)0.0191 (3)
H5A0.24470.67100.45650.023*
H5B0.10660.86390.46130.023*
C60.2997 (2)0.77262 (18)0.57925 (10)0.0201 (3)
H6A0.29020.88690.59730.024*
H6B0.17950.72810.62060.024*
C70.7198 (2)0.71363 (18)0.53092 (9)0.0195 (3)
H7A0.86760.63120.54170.023*
H7B0.73250.82460.54670.023*
C80.6760 (2)0.72468 (17)0.42325 (10)0.0191 (3)
H8A0.79570.77010.38220.023*
H8B0.68600.61070.40470.023*
C90.5772 (2)0.58513 (17)0.69070 (10)0.0195 (3)
C100.3966 (3)0.57581 (19)0.76644 (11)0.0273 (3)
H100.24110.63070.75710.033*
C110.4545 (3)0.4840 (2)0.85437 (11)0.0326 (4)
H110.33730.47540.90520.039*
C120.6857 (3)0.4044 (2)0.86779 (11)0.0335 (4)
H120.72770.33930.92630.040*
C130.8513 (3)0.4253 (2)0.79115 (11)0.0317 (4)
H131.00800.37430.80020.038*
Cl10.15611 (8)1.19962 (6)0.03723 (3)0.04376 (16)
N10.1002 (2)1.04206 (16)0.21036 (9)0.0273 (3)
N20.1664 (2)0.95301 (15)0.29644 (8)0.0240 (3)
N30.44321 (19)0.83591 (14)0.40660 (8)0.0185 (3)
N40.53064 (19)0.66186 (14)0.59658 (8)0.0190 (3)
N50.8031 (2)0.51407 (15)0.70410 (9)0.0259 (3)
U11U22U33U12U13U23
C10.0272 (8)0.0267 (8)0.0218 (7)−0.0052 (6)−0.0029 (6)0.0016 (6)
C20.0253 (8)0.0305 (8)0.0236 (7)−0.0119 (7)0.0053 (6)−0.0019 (6)
C30.0171 (7)0.0278 (8)0.0256 (7)−0.0084 (6)0.0024 (6)−0.0035 (6)
C40.0171 (7)0.0169 (7)0.0215 (7)−0.0052 (5)0.0011 (5)−0.0050 (5)
C50.0120 (7)0.0230 (7)0.0219 (7)−0.0054 (6)0.0007 (5)−0.0006 (5)
C60.0129 (7)0.0240 (7)0.0220 (7)−0.0033 (6)0.0015 (5)−0.0015 (6)
C70.0121 (7)0.0226 (7)0.0239 (7)−0.0057 (6)−0.0001 (5)−0.0010 (5)
C80.0107 (7)0.0217 (7)0.0239 (7)−0.0031 (5)0.0017 (5)−0.0028 (5)
C90.0198 (7)0.0182 (7)0.0219 (7)−0.0057 (6)−0.0031 (6)−0.0033 (5)
C100.0208 (8)0.0327 (8)0.0262 (8)−0.0048 (7)−0.0005 (6)0.0011 (6)
C110.0320 (9)0.0415 (9)0.0236 (8)−0.0123 (8)0.0016 (7)0.0023 (7)
C120.0369 (10)0.0389 (9)0.0240 (8)−0.0077 (8)−0.0103 (7)0.0045 (7)
C130.0246 (9)0.0378 (9)0.0314 (8)−0.0030 (7)−0.0101 (7)0.0000 (7)
Cl10.0423 (3)0.0562 (3)0.0281 (2)−0.0095 (2)−0.00750 (18)0.01386 (18)
N10.0230 (7)0.0329 (7)0.0246 (6)−0.0060 (6)−0.0038 (5)0.0034 (5)
N20.0166 (6)0.0297 (7)0.0242 (6)−0.0054 (5)−0.0023 (5)0.0033 (5)
N30.0115 (6)0.0229 (6)0.0198 (6)−0.0039 (5)0.0009 (4)0.0001 (5)
N40.0119 (6)0.0230 (6)0.0209 (6)−0.0042 (5)0.0003 (5)0.0007 (5)
N50.0201 (7)0.0307 (7)0.0259 (7)−0.0037 (5)−0.0052 (5)−0.0014 (5)
C1—N11.3071 (19)C7—H7A0.9700
C1—C21.388 (2)C7—H7B0.9700
C1—Cl11.7401 (16)C8—N31.4661 (18)
C2—C31.3574 (19)C8—H8A0.9700
C2—H20.9300C8—H8B0.9700
C3—C41.4170 (18)C9—N51.3377 (18)
C3—H30.9300C9—N41.3909 (17)
C4—N21.3401 (18)C9—C101.405 (2)
C4—N31.3784 (17)C10—C111.372 (2)
C5—N31.4617 (17)C10—H100.9300
C5—C61.5104 (19)C11—C121.378 (2)
C5—H5A0.9700C11—H110.9300
C5—H5B0.9700C12—C131.372 (2)
C6—N41.4582 (18)C12—H120.9300
C6—H6A0.9700C13—N51.3402 (18)
C6—H6B0.9700C13—H130.9300
C7—N41.4635 (17)N1—N21.3534 (16)
C7—C81.5159 (19)
N1—C1—C2124.64 (13)N3—C8—C7110.54 (11)
N1—C1—Cl1115.24 (12)N3—C8—H8A109.5
C2—C1—Cl1120.12 (11)C7—C8—H8A109.5
C3—C2—C1117.20 (13)N3—C8—H8B109.5
C3—C2—H2121.4C7—C8—H8B109.5
C1—C2—H2121.4H8A—C8—H8B108.1
C2—C3—C4117.76 (14)N5—C9—N4116.30 (12)
C2—C3—H3121.1N5—C9—C10121.67 (13)
C4—C3—H3121.1N4—C9—C10121.97 (13)
N2—C4—N3116.16 (11)C11—C10—C9118.58 (14)
N2—C4—C3121.66 (12)C11—C10—H10120.7
N3—C4—C3122.04 (13)C9—C10—H10120.7
N3—C5—C6111.31 (11)C10—C11—C12120.29 (14)
N3—C5—H5A109.4C10—C11—H11119.9
C6—C5—H5A109.4C12—C11—H11119.9
N3—C5—H5B109.4C13—C12—C11117.17 (14)
C6—C5—H5B109.4C13—C12—H12121.4
H5A—C5—H5B108.0C11—C12—H12121.4
N4—C6—C5110.91 (11)N5—C13—C12124.63 (14)
N4—C6—H6A109.5N5—C13—H13117.7
C5—C6—H6A109.5C12—C13—H13117.7
N4—C6—H6B109.5C1—N1—N2119.04 (12)
C5—C6—H6B109.5C4—N2—N1119.68 (11)
H6A—C6—H6B108.0C4—N3—C5118.35 (11)
N4—C7—C8111.62 (11)C4—N3—C8121.18 (11)
N4—C7—H7A109.3C5—N3—C8112.41 (11)
C8—C7—H7A109.3C9—N4—C6120.47 (11)
N4—C7—H7B109.3C9—N4—C7118.98 (11)
C8—C7—H7B109.3C6—N4—C7112.49 (11)
H7A—C7—H7B108.0C9—N5—C13117.56 (12)
N1—C1—C2—C30.4 (2)C3—C4—N3—C5−176.37 (12)
Cl1—C1—C2—C3−179.57 (11)N2—C4—N3—C8154.15 (12)
C1—C2—C3—C4−0.8 (2)C3—C4—N3—C8−30.0 (2)
C2—C3—C4—N21.2 (2)C6—C5—N3—C4−155.41 (12)
C2—C3—C4—N3−174.44 (13)C6—C5—N3—C855.41 (15)
N3—C5—C6—N4−54.49 (15)C7—C8—N3—C4157.23 (12)
N4—C7—C8—N353.56 (15)C7—C8—N3—C5−54.57 (15)
N5—C9—C10—C11−3.3 (2)N5—C9—N4—C6−167.32 (12)
N4—C9—C10—C11173.85 (13)C10—C9—N4—C615.4 (2)
C9—C10—C11—C120.6 (2)N5—C9—N4—C7−20.90 (18)
C10—C11—C12—C131.6 (3)C10—C9—N4—C7161.84 (13)
C11—C12—C13—N5−1.5 (3)C5—C6—N4—C9−156.99 (12)
C2—C1—N1—N2−0.3 (2)C5—C6—N4—C754.58 (15)
Cl1—C1—N1—N2179.64 (10)C8—C7—N4—C9156.51 (12)
N3—C4—N2—N1174.73 (12)C8—C7—N4—C6−54.56 (15)
C3—C4—N2—N1−1.2 (2)N4—C9—N5—C13−173.88 (13)
C1—N1—N2—C40.7 (2)C10—C9—N5—C133.4 (2)
N2—C4—N3—C57.76 (18)C12—C13—N5—C9−1.0 (2)
D—H···AD—HH···AD···AD—H···A
C3—H3···N1i0.932.583.346 (3)140
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C3—H3⋯N1i0.932.583.346 (3)140

Symmetry code: (i) .

  11 in total

1.  SYNTHESIS AND PHARMACOLOGICAL STUDY OF NEW PIPERAZINE DERIVATIVES. I. BENZYLPIPERAZINES.

Authors:  J R BOISSIER; R RATOUIS; C DUMONT
Journal:  J Med Chem       Date:  1963-09       Impact factor: 7.446

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  [(3-Chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents.

Authors:  Maria Paola Giovannoni; Claudia Vergelli; Carla Ghelardini; Nicoletta Galeotti; Alessandro Bartolini; Vittorio Dal Piaz
Journal:  J Med Chem       Date:  2003-03-13       Impact factor: 7.446

4.  Synthesis and antinociceptive activity of 6-substituted-3-pyridazinone derivatives.

Authors:  M Gokçe; D Dogruer; M F Sahin
Journal:  Farmaco       Date:  2001-03

5.  Synthesis of new Mannich bases of arylpyridazinones as analgesic and anti-inflammatory agents.

Authors:  Mehtap Gökçe; Gökçen Bakir; Mustafa Fethi Sahin; Esra Küpeli; Erdem Yeşilada
Journal:  Arzneimittelforschung       Date:  2005

6.  Synthesis and analgesic and anti-inflammatory activity of ethyl (6-substituted-3 (2H)-pyridazinone-2-yl)acetate derivatives.

Authors:  Yasemin Dündar; Mehtap Gökçe; Esra Küpeli; Mustafa Fethi Sahin
Journal:  Arzneimittelforschung       Date:  2007

7.  Synthesis and analgesic and anti-inflammatory activities 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(p-substituted/nonsubstituted benzal)hydrazone derivatives.

Authors:  Mehtap Gökçe; Semra Utku; Esra Küpeli
Journal:  Eur J Med Chem       Date:  2009-05-09       Impact factor: 6.514

8.  Synthesis and evaluation of the analgesic and anti-inflammatory activity of new 3(2H)-pyridazinone derivatives.

Authors:  Mehtap Gökçe; Mustafa Fethi Sahin; Esra Küpeli; Erdem Yeşilada
Journal:  Arzneimittelforschung       Date:  2004

9.  Amide derivatives of [6-(5-methyl-3-phenylpyrazole-1-yl)-3(2H)-pyridazinone-2-yl]acetic acids as potential analgesic and anti-inflammatory compounds.

Authors:  Erden Banoglu; Cağla Akoğlu; Serdar Unlü; Esra Küpeli; Erdem Yeşilada; M Fethi Sahin
Journal:  Arch Pharm (Weinheim)       Date:  2004-01       Impact factor: 3.751

10.  Synthesis and analgesic and antiinflammatory activity of methyl 6-substituted-3(2h)-pyridazinone-2-ylacetate derivatives.

Authors:  M F Sahina; B Badiçoglu; M Gökçe; E Küpeli; E Yeşilada
Journal:  Arch Pharm (Weinheim)       Date:  2004-08       Impact factor: 3.751

View more
  1 in total

1.  3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine.

Authors:  Hakan Arslan; Semra Utku; Kenneth I Hardcastle; Mehtap Gökçe; Sheri Lense
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.